11.07
price up icon0.91%   0.10
after-market Handel nachbörslich: 11.07
loading
Schlusskurs vom Vortag:
$10.97
Offen:
$10.91
24-Stunden-Volumen:
21,114
Relative Volume:
0.50
Marktkapitalisierung:
$44.77M
Einnahmen:
$147.75M
Nettoeinkommen (Verlust:
$-284.23M
KGV:
-3.7782
EPS:
-2.93
Netto-Cashflow:
$-317.54M
1W Leistung:
+0.00%
1M Leistung:
-7.98%
6M Leistung:
+47.65%
1J Leistung:
+29.06%
1-Tages-Spanne:
Value
$10.57
$11.24
1-Wochen-Bereich:
Value
$10.29
$11.55
52-Wochen-Spanne:
Value
$4.50
$21.94

Fibrogen Inc Stock (FGEN) Company Profile

Name
Firmenname
Fibrogen Inc
Name
Telefon
415-978-1200
Name
Adresse
350 BAY STREET, SAN FRANCISCO, CA
Name
Mitarbeiter
225
Name
Twitter
@FibroGenInc
Name
Nächster Verdiensttermin
2025-03-17
Name
Neueste SEC-Einreichungen
Name
FGEN's Discussions on Twitter

Vergleichen Sie FGEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
FGEN
Fibrogen Inc
11.07 44.36M 147.75M -284.23M -317.54M -2.93
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Fibrogen Inc Stock (FGEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-08-08 Herabstufung BofA Securities Neutral → Underperform
2023-06-26 Herabstufung BofA Securities Buy → Neutral
2023-06-26 Herabstufung Raymond James Outperform → Mkt Perform
2023-06-26 Herabstufung Stifel Buy → Hold
2023-06-26 Herabstufung William Blair Outperform → Mkt Perform
2023-06-02 Hochstufung Stifel Hold → Buy
2023-01-31 Hochstufung William Blair Mkt Perform → Outperform
2023-01-26 Hochstufung Raymond James Mkt Perform → Outperform
2023-01-05 Hochstufung BofA Securities Neutral → Buy
2021-09-22 Herabstufung Goldman Neutral → Sell
2021-08-20 Hochstufung Raymond James Underperform → Mkt Perform
2021-07-16 Herabstufung BofA Securities Buy → Neutral
2021-07-16 Herabstufung Stifel Buy → Hold
2021-04-07 Herabstufung H.C. Wainwright Buy → Neutral
2021-04-07 Herabstufung Mizuho Buy → Neutral
2021-03-31 Hochstufung BofA Securities Neutral → Buy
2021-03-02 Herabstufung Jefferies Buy → Hold
2021-02-01 Eingeleitet H.C. Wainwright Buy
2020-10-26 Eingeleitet Raymond James Underperform
2020-07-10 Fortgesetzt Stifel Buy
2020-05-01 Eingeleitet Cowen Market Perform
2020-04-27 Eingeleitet BofA/Merrill Neutral
2019-05-29 Fortgesetzt Goldman Neutral
2019-05-10 Herabstufung William Blair Outperform → Mkt Perform
2019-04-12 Eingeleitet Piper Jaffray Neutral
2019-02-11 Fortgesetzt Stifel Buy
2018-12-19 Hochstufung Citigroup Neutral → Buy
2017-08-08 Bestätigt Leerink Partners Outperform
2017-08-08 Bestätigt Stifel Buy
2017-07-21 Herabstufung Goldman Buy → Neutral
2017-07-11 Eingeleitet Jefferies Buy
2016-02-11 Hochstufung Credit Suisse Neutral → Outperform
2016-01-21 Eingeleitet Credit Suisse Neutral
2015-12-04 Eingeleitet Citigroup Buy
2015-09-23 Eingeleitet Lake Street Hold
2015-07-29 Eingeleitet Citigroup Buy
2015-07-20 Hochstufung Goldman Neutral → Buy
2014-12-09 Eingeleitet Stifel Buy
Alle ansehen

Fibrogen Inc Aktie (FGEN) Neueste Nachrichten

pulisher
06:22 AM

How to read the order book for FibroGen Inc.2025 Market Outlook & AI Forecast Swing Trade Picks - newser.com

06:22 AM
pulisher
04:08 AM

Will FibroGen Inc. (1FG0) stock see valuation expansionJuly 2025 Market Mood & Weekly Momentum Picks - newser.com

04:08 AM
pulisher
02:39 AM

Forecasting FibroGen Inc. price range with options dataMarket Growth Review & Fast Exit and Entry Trade Guides - newser.com

02:39 AM
pulisher
Oct 13, 2025

How FibroGen Inc. (1FG0) stock reacts to monetary easingWatch List & Technical Buy Zone Confirmation - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What hedge fund activity signals for FibroGen Inc. stockEarnings Risk Report & Fast Momentum Entry Tips - newser.com

Oct 13, 2025
pulisher
Oct 10, 2025

Real time breakdown of FibroGen Inc. stock performance2025 Short Interest & Growth Oriented Trading Recommendations - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Risk vs reward if holding onto FibroGen Inc.Market Rally & AI Driven Price Predictions - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Sentiment analysis tools applied to FibroGen Inc.July 2025 Technicals & High Conviction Buy Zone Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Applying Wyckoff theory to FibroGen Inc. stockInflation Watch & Consistent Return Investment Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Can you recover from losses in FibroGen Inc.Market Growth Summary & Real-Time Volume Analysis - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Relative strength of FibroGen Inc. in sector analysis2025 Historical Comparison & Verified Short-Term Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Custom watchlist performance reports with FibroGen Inc.2025 Macro Impact & Verified Momentum Watchlists - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Real time social sentiment graph for FibroGen Inc.Earnings Beat & Intraday High Probability Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is now a turning point for FibroGen Inc.2025 Price Action Summary & AI Driven Price Forecasts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Real time scanner hits for FibroGen Inc. explainedTrade Risk Assessment & Daily Volume Surge Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Long term hold vs stop loss in FibroGen Inc.2025 Trading Volume Trends & Entry Point Confirmation Signals - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Live market analysis of FibroGen Inc.Buy Signal & Expert Approved Momentum Trade Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Reversal indicators forming on FibroGen Inc. stockInflation Watch & Fast Exit and Entry Strategy Plans - newser.com

Oct 06, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 05:46:29 - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

What analysts say about FibroGen Inc stockMid Cap Growth Trends & Maximize ROI With Proven Growth Stocks - earlytimes.in

Oct 02, 2025
pulisher
Oct 01, 2025

FibroGen Inc Stock Analysis and ForecastEquity Performance Review & High Return Portfolio Growth - earlytimes.in

Oct 01, 2025
pulisher
Sep 29, 2025

What drives FibroGen Inc stock priceMonthly Performance Summary & Reap the Rewards of Patience + Planning - earlytimes.in

Sep 29, 2025
pulisher
Sep 29, 2025

What analysts say about FibroGen Inc 1FG0 stockBollinger Bands Signals & Exceptional Capital Growth - earlytimes.in

Sep 29, 2025
pulisher
Sep 25, 2025

FibroGen stock advances as H.C. Wainwright reiterates Buy rating on FG-3246 progress - Investing.com Nigeria

Sep 25, 2025
pulisher
Sep 25, 2025

FibroGen stock advances as H.C. Wainwright reiterates Buy rating on FG-3246 progress By Investing.com - Investing.com South Africa

Sep 25, 2025
pulisher
Sep 25, 2025

William Blair Remains a Hold on FibroGen (FGEN) - The Globe and Mail

Sep 25, 2025

Finanzdaten der Fibrogen Inc-Aktie (FGEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Fibrogen Inc-Aktie (FGEN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Wettig Thane
CEO
Mar 24 '25
Buy
0.35
145,000
50,663
543,329
Schoeneck James A
Director
Mar 20 '25
Buy
0.35
250,000
88,000
323,722
Schoeneck James A
Director
Mar 21 '25
Buy
0.34
50,000
17,040
373,722
$21.75
price down icon 5.47%
$85.96
price up icon 1.59%
$32.75
price up icon 0.41%
$102.61
price up icon 0.29%
$161.38
price down icon 1.45%
biotechnology ONC
$320.94
price down icon 1.85%
Kapitalisierung:     |  Volumen (24h):